Haorui Patrick Zhang

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto.

Encoded Therapeutics, Inc. operates as a biotechnology company that engages in the development of precision medicines and therapy for genetic disorders. It focuses on viral gene therapies. The company was founded by Kartik Ramamoorthi and Stephanie Tagliatela and is headquartered in South San Francisco, CA.

Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company was founded by Molly He and is headquartered in San Diego, CA.

Kelonia Therapeutics, Inc. is a company based in Cambridge, MA that is pioneering a new wave of genetic medicines using its in vivo gene placement system (iGPS™). The company's simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. Initially focused on developing transformational in vivo CAR T therapies for hematologic cancers, Kelonia Therapeutics is building a pipeline of genetic medicines for a range of diseases, with the bold goal of making genetic medicines accessible to every patient in need, when and where they need them. The company was founded by Michael Fischbach, Michael Birnbaum.

Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA.

Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.

Company Builders LLC provides business development consulting services. The private company is based in Albuquerque, NM. The CEO of the company is Paul Andrew Ruppanner.

Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks.

Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

Part of Iron Mountain, Inc., Novo Holdings Ltd. functions as an investment holding British company. The company is based in London, UK.

Technion Research & Development Foundation Ltd. supports technical research and engineering development projects. The company was founded on February 19, 1952 and is headquartered in Haifa, Israel.

Ares Life Sciences LP provides financing for small and medium sized companies. It focuses on key life sciences sectors, mainly: pharmaceuticals and biotechnology, medical diagnostics, and medical technology.

Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006.

Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.

Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France.

Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation.

LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA.

Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA.

Lygos, Inc. engages in the development of full-stack biological engineering platform. Its platform focuses on organic acid specialty chemicals and bio-monomers. The company was founded by Eric Steen, Jeffrey Dietrich, Jay D. Keasling, Leonard Katz, and J. L. Clem Fortman in 2010 and is headquartered in Berkeley, CA.

Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse.

ResVita Bio, Inc. is a company based in Berkeley, CA that aims to restore and maintain the vitality of the skin through the topical application of cellular therapies. ResVita Bio genetically programs living cells to repair disrupted skin and alleviate inflammation in various inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, acne rosacea, and psoriasis. The company has received several awards, including the Bakar Innovation Fellowship, NIAMS SBIR Award, NIAID SBIR Award, and the AbbVie Golden Ticket at UC Berkeley's Bakar Labs. ResVita Bio is developing a safe and versatile skin probiotic platform through synthetic biology and metabolic engineering to continuously deliver therapies that directly treat inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, chronic wound infection, and psoriasis. The company was founded by Amin Zargar and Jay D. Keasling, with Amin Zargar serving as the CEO since incorporation.

OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois.